Alpha1-AR-mediated activation of NKCC in rat cardiomyocytes involves ERK-dependent phosphorylation of the cotransporter

Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1354-60. doi: 10.1152/ajpheart.00549.2003. Epub 2003 Nov 20.

Abstract

We studied molecular and functional characteristics as well as hormonal regulation of the Na-K-2Cl cotransporter (NKCC) in the isolated rat heart and cardiomyocytes. NKCC activity was measured as bumetanide-sensitive (86)Rb(+) influx in isolated perfused rat hearts and isolated cardiomyocytes. Stimulation of alpha(1)-adrenoceptors (AR) by phenylephrine (30 microM) increased (86)Rb(+) influx. The NKCC inhibitor bumetanide (50 microM) reduced the response to phenylephrine by 45 +/- 13% (n = 12, P < 0.01). PD-98059 (10 microM), an inhibitor of the activation of the mitogen-activated protein kinases extracellular signal-regulated protein kinase 1 and 2 (ERK1/2), reduced the total response to phenylephrine by 51 +/- 13% (n = 10, P < 0.01) and eliminated the bumetanide-sensitive component, indicating that alpha(1)-AR mediated stimulation of NKCC is dependent on activation of ERK1/2. Inhibitors of protein kinase C or phosphatidylinositol 3-kinase had no effect. The presence of NKCC mRNA and protein was demonstrated in isolated rat cardiomyocytes. Phosphorylation of NKCC after alpha(1)-AR stimulation was shown by immunoprecipitation of the phosphoprotein from (32)P(i) prelabeled cardiomyocytes. Increased phosphorylation of the NKCC protein was also abolished by PD-98059. We conclude that the NKCC is present in rat cardiomyocytes and that ion transport by the cotransporter is regulated by alpha(1)-AR stimulation through phosphorylation of this protein involving the ERK pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biotransformation
  • Bumetanide / pharmacology
  • Cell Separation
  • Diuretics / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Immunoblotting
  • In Vitro Techniques
  • Male
  • Marine Toxins
  • Mitogen-Activated Protein Kinases / physiology*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / enzymology*
  • Oxazoles / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, alpha-1 / physiology*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Rubidium Radioisotopes
  • Sodium / physiology
  • Sodium Potassium Chloride Symporter Inhibitors
  • Sodium-Potassium-Chloride Symporters / biosynthesis
  • Sodium-Potassium-Chloride Symporters / metabolism*
  • Solute Carrier Family 12, Member 1

Substances

  • Diuretics
  • Enzyme Inhibitors
  • Marine Toxins
  • Oxazoles
  • Phosphoinositide-3 Kinase Inhibitors
  • RNA, Messenger
  • Receptors, Adrenergic, alpha-1
  • Rubidium Radioisotopes
  • Slc12a1 protein, rat
  • Sodium Potassium Chloride Symporter Inhibitors
  • Sodium-Potassium-Chloride Symporters
  • Solute Carrier Family 12, Member 1
  • Bumetanide
  • calyculin A
  • Sodium
  • Mitogen-Activated Protein Kinases